| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.16 | 0.0007 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |